Covid-19 Drug Remdesivir to Cost $3,120 for Typical Patient on Private Insurance – WSJ

Gilead Sciences disclosed its pricing plans as it prepares to begin charging for remdesivir in July. The U.S. has been distributing the drug donated by Gilead since it was authorized for emergency use in May.

Source: Covid-19 Drug Remdesivir to Cost $3,120 for Typical Patient on Private Insurance – WSJ


The article was originally published here!

Comments

Popular posts from this blog

Pier 1 Closing All Stores For Good, Cites ‘New Reality, Uncertainty Of Post-COVID World’

US formally withdraws from Open Skies Treaty that bolstered European security – CNNPolitics

Today’s Top Stories: March 30, 2020